| abstract |
The present application relates to novel heterocyclic-substituted 1-carboylmethyl-3-aryl-1,2,4-triazol-5-ones, to processes for preparation thereof, to the use thereof alone or in combination for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of cardiovascular disorders. The compounds are vasopressin receptor antagonists. |